Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Griffiths

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2020
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysisNick van Es, Matthew Ventresca, Marcello Di Nisio, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 2, 2024
Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trialPaul Little, Katherine Bradbury, Beth Stuart, et al.
Nature Communications|August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesotheliomaMin Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Nature Communications|June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2020
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysisNick van Es, Matthew Ventresca, Marcello Di Nisio, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 2, 2024
Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trialPaul Little, Katherine Bradbury, Beth Stuart, et al.
Nature Communications|August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesotheliomaMin Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Pageof 25